Pharma Industry Urged to Move AI from Pilot to Production
The pharmaceutical industry is encouraged to transition artificial intelligence (AI) applications from pilot projects to full production. This shift aims to unlock AI's potential in drug development, manufacturing, and business operations, enhancing efficiency and innovation. EPAM highlights the importance of building a strong business case to support this move and realize AI's benefits in pharma.
EPAM·



